31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer. (December 2022)

Record Type:
Journal Article
Title:
31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer. (December 2022)
Main Title:
31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer
Authors:
Joode, K.D.
Groen, H.J.M.
van den Heuvel, M.
Kloover, J.S.
van der Meer, F.
Stigt, J.A.
van der Leest, C.H.
Van Den Borne, B.
de Wijn, R.
Hurkmans, D.P.
van den Heuvel, D.M.A.
van Doorn, T.
Pinedo, B.
Kapiteijn, E.
Debets, R.
Verdegaal, E.
van der Burg, S.H.
Groten, J.P.
Aerts, J.G.
Mathijssen, R.H.
Abstract:
Is Part Of:
Immuno-oncology technology. Volume 16(2022)Supplement 1
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Issue Display:
Volume 16, Issue 1 (2022)
Year:
2022
Volume:
16
Issue:
1
Issue Sort Value:
2022-0016-0001-0000
Page Start:
Page End:
Publication Date:
2022-12
Subjects:
Cancer -- Immunotherapy -- Periodicals
616.994061
Journal URLs:
https://www.esmoiotech.org/issues ↗
http://www.sciencedirect.com/ ↗
DOI:
10.1016/j.iotech.2022.100136 ↗
Languages:
English
ISSNs:
2590-0188
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
24685.xml